Your trusted source for investing success

Tag: trials

Are You Aware of the FDA's Plans for 2018?

Find out what's going on in our new report
 
Harvest One Announces Retail Platform and Branding Strategy

Harvest One Announces Retail Platform and Branding Strategy

Harvest One Cannabis Inc. (TSXV:HVST) (“Harvest One” or the “Company”) through its wholly owned subsidiary United Greeneries (“United Greeneries” or “UG”) is pleased to announce the launch of retail sales beginning February 2018;
Retail sales to commence February 2018
Over 325 kg of dried cannabis currently in stock for immediate sale
Initial import license

Revive Therapeutics Announces Update on its Collaboration Agreement with Health Canada Licensed Dealer for Medical Cannabis…

Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV)(OTCQB:RVVTF), a company focused on the research, development and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid-based pharmaceutical markets, today announced an update on the Company’s collaboration agreement with Chemi Pharmaceutical Inc. (“Chemi Pharma”), a Licensed Dealer for

4 Small Medical Device Companies to Watch

4 Small Medical Device Companies to Watch

Now that 2017 is behind us, the INN takes a closer look at some medical device companies with interesting paths ahead of them in 2018–be it from upcoming trials, recent approvals or potential developments on the horizon.

CVR Medical, Canon Sign Manufacturing Agreement for Breakthrough Device

CVR Medical Corp. (TSXV:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) announces the signing of a manufacturing agreement with Canon Virginia, Inc., a manufacturing, engineering and technical operation for Canon and a wholly owned subsidiary of Canon U.S.A. The agreement finalizes Canon Virginia’s status as primary manufacturer, assembler, and logistical authority

Are You Aware of the FDA's Plans for 2018?

Find out what's going on in our new report
 
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/cbmg-accelerates-cell-therapy-manufacturing-ge-healthcares-new-start-finish-solution/